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ABSTRACT: Orange juice is a rich source of (poly)phenols, in particular the flavanones 1 
hesperetin-7-O-rutinoside and naringenin-7-O-rutinoside. Following the acute consumption 2 
of 500 mL of orange juice containing 398 µmol of (poly)phenols by 12 volunteers, 0-24 h 3 
plasma and urine samples were analysed by targeted high-performance liquid 4 
chromatography-high resolution-mass spectrometry in order to identify flavanone 5 
metabolites and phenolic acid and aromatic catabolites. A total of 19 flavanone metabolites 6 
which comprised di-O-glucuronide, O-glucuronide, O-glucuronyl-sulfate, and sulfate 7 
derivatives of hesperetin, naringenin and eriodictyol, and 65 microbial-derived phenolic 8 
catabolites, such as phenylpropanoid, phenylpropionic, phenylacetic, benzoic and 9 
hydroxycarboxylic acids and benzenetriol and benzoylglycine derivatives, including free 10 
phenolics and phase II sulfate, glucuronide and methyl metabolites, were identified or 11 
partially identified in plasma and/or urine samples. The data obtained provide a detailed 12 
evaluation of the fate of orange juice (poly)phenols as they pass through the gastrointestinal 13 
tract, and are absorbed into circulatory systems prior to renal excretion.  Potential pathways 14 
for these conversions are proposed.  15 
 16 
KEYWORDS:   orange juice, flavanones, HPLC-HR-MS identification, urinary and plasma 17 
metabolites; colon-derived phenolic catabolites, bioavailability, humans 18 
 19 
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INTRODUCTION 20 
Human intervention trials have provided evidence for the protective effects against chronic 21 
diseases of a fruit and vegetable (poly)phenol-rich diet.1,2 Fruit juices represent a further 22 
option for consumers to increase their intake of (poly)phenols. In particular, orange juice (OJ) 23 
is of interest due to its widespread consumption and high flavanone content, predominantly in 24 
the form of hesperetin-7-O-rutinoside and naringenin-7-O-rutinoside3. Epidemiological 25 
prospective studies have shown consistent associations between the intake of flavanone-26 
containing citrus fruit and prevention of various types of cancer,4,5,6 and regular consumption 27 
of OJ has been linked to improved vascular function.7 28 
Among the factors necessary to elucidate the mode of action underlying the potential 29 
protective effects of flavanones in humans, is an understanding of the absorption, disposition, 30 
metabolism and excretion (aka bioavailability) of flavanones in vivo. Following ingestion, OJ 31 
flavanones were, until recently, considered to be poorly bioavailable with only relatively small 32 
amounts of the ingested dose entering the systemic circulation, not as the parent compounds 33 
but as phase II metabolites, mainly glucuronide and sulfate derivatives, with studies reporting 34 
peak plasma concentration ranging from 63 to 1500 nM8,9 and urinary recoveries <5-16% of 35 
intake.10-13 Research with ileostomists has shown that ~70% of ingested flavanones pass to 36 
the colon14 where they are degraded by the action of the microbiota giving rise, principally to 37 
small phenolic and aromatic acid catabolites10-11 which are absorbed into the circulatory 38 
system. When urinary excretion of the phase II flavanone metabolites and the colonic 39 
catabolites are taken into account the bioavailability of OJ flavanones increases markedly.10 40 
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To date, a number of studies have investigated the absorption, metabolism and 41 
excretion of OJ (poly)phenols in humans8-13,15,16 and most have focused on the analysis of 42 
flavanone metabolites in plasma and/or urine, without taking in consideration the major 43 
transformations mediated principally by the colonic microbiota.  The aim of this study was to 44 
apply targeted HPLC-HR-MS methodology, which provides high sensitivity and selectivity, to 45 
obtain detailed and novel information on the identity of metabolites and colon-derived 46 
phenolic catabolites in plasma and urine 0-24 h after acute consumption of 500 mL of OJ by 12 47 
physically-fit male volunteers. 48 
 49 
MATERIAL AND METHODS 50 
Chemicals and Reagents. 4-Hydroxybenzoic acid, 3-hydroxybenzoic acid, ferulic acid, 51 
isoferulic acid, 4´-hydroxyphenylacetic acid, 3´-hydroxyphenylacetic acid, 3´,4´-52 
dimethoxyphenylacetic acid, 3´-methoxy-4´-hydroxyphenylacetic acid (homovanillic acid), 53 
hippuric acid, 3,4-dihydroxybenzoic acid (protocatechuic acid), 3-methoxy-4-hydroxybenzoic 54 
acid (vanillic acid), 3-hydroxy-4-methoxybenzoic acid (isovanillic acid), 3-(3´-methoxy-4´-55 
hydroxyphenyl)propionic acid (dihydroferulic acid), 3-(3´-hydroxy-4´-56 
methoxyphenyl)propionic acid (dihydroisoferulic acid), 3-(3´-methoxy-4´-hydroxy)mandelic 57 
acid, 4´-hydroxymandelic acid, 3-(3´,4´-dihydroxyphenyl)propionic acid (dihydrocaffeic acid), 58 
3-(3´,4´-dihydroxyphenyl)acetic acid (homoprotocatechuic acid),  3-(4´-59 
hydroxyphenyl)propionic acid, sinapic acid, phenylacetic acid, 3-(phenyl)propionic acid, 1,3,5-60 
trihydroxyphenol (phloroglucinol), 1,2,3-trihydroxyphenol (pyrogallol) and 1,2-61 
dihydroxyphenol (catechol), 3´-hydroxycinnamic acid (m-coumaric acid), 4´-hydroxycinnamic 62 
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acid (p-coumaric acid) and p-sympatol were purchased from Sigma-Aldrich (Poole, Dorset, 63 
U.K.).  3´-Hydroxyhippuric acid, 3-(3´-hydroxyphenyl)hydracrylic acid, hesperetin-7-O-64 
glucuronide, naringenin-4´-O-glucuronide, and naringenin-7-O-glucuronide were purchased 65 
from Toronto Research Chemicals (Toronto, ON, Canada). Coumaric acid-3´-O-glucuronide, 66 
coumaric acid-4´-O-glucuronide, caffeic acid-3´-O-glucuronide, caffeic acid-3´-sulfate, caffeic 67 
acid 4´-O-glucuronide, caffeic acid 4´-sulfate, ferulic acid-4´-O-glucuronide, ferulic acid-4´-68 
sulfate, isoferulic acid-3´-O-glucuronide, 3-(3´-hydroxyphenyl)propionic acid-4´-O-glucuronide 69 
(dihydrocaffeic acid-4'-O-glucuronide), 3-(phenyl)propionic acid-4´-O-glucuronide, 3-(4´-70 
hydroxyphenyl)propionic acid-3'-O-glucuronide (dihydrocaffeic acid-3'-O-glucuronide), 3-(3´-71 
hydroxyphenyl)propionic acid-4´-sulfate (dihydrocaffeic acid-4'-sulfate), 3-(4´-72 
hydroxyphenyl)propionic acid-3´-sulfate(dihydrocaffeic acid-3'-sulfate), 3-(3´-73 
methoxyphenyl)propionic acid-4´-O-glucuronide (dihydroferulic acid-4´-O-glucuronide), 3-(4´-74 
methoxyphenyl)propionic-acid-3´-O-glucuronide (dihydro-isoferulic acid-3´-O-glucuronide) 75 
and 3-(3´-methoxyphenyl)propionic-acid-4´-sulfate (dihydroferulic acid-4´-sulfate) were 76 
kindly provided by Denis Barron (Nestle Research Center, Lausanne, Switzerland) and Gary 77 
Williamson (School of Food Science and Nutrition, University of Leeds, UK). 4´-78 
Hydroxyhippuric acid was obtained from Bachem (UK) Ltd (St Helens, UK). 3-(3'-79 
Hydroxyphenyl)propionic acid was supplied by Fluorochem (Derby, UK).  3-(3′-Hydroxy-4′-80 
methoxyphenyl)hydracrylic acid was isolated in a previous study.10 Hesperetin-7-O-rutinoside 81 
(hesperidin), 4´-O-methyl-naringenin-7-O-rutinoside (didymin), and naringenin-7-O-82 
rutinoside (narirutin) were obtained from Extrasyntheses (Genay, France). Hesperetin-3'-83 
sulfate was a generous gift from Dr. Christine Morand (INRA/Clemont-Ferrand, France).  84 
Formic acid and HPLC-MS grade methanol were obtained from Panreac (Barcelona, Spain).  85 
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Study Design. Twelve men aged 31.8 ± 5.7 years, with a body mass index  of 21.7 ± 1.8 86 
kg/m2 mean value ± SD) volunteered to participate in this study. All trained regularly, were fit, 87 
healthy normotensive non-smokers and were not taking any drug therapies or supplements. 88 
Other exclusion criteria included: history of gastrointestinal disease, eating disorders and 89 
being vegetarian. Written informed consent was provided by all participants. The study 90 
protocol was approved by the College of Medical, Veterinary and Life Sciences Ethics 91 
Committee of the University of Glasgow and registered at BioMed Central Ltd. 92 
(http://www.controlledtrials.com/ISRCTN04271658). 93 
Before attending the clinic, participants were asked to follow a low (poly)phenol diet for 2 94 
days by avoiding fruits and vegetables, nuts, high-fibre products, chocolate and beverages such 95 
as tea, coffee and fruit juices, as well as to abstain from consuming alcohol. On the morning of 96 
the feeding trial, volunteers reported to the metabolic suite between 08.00 and 09.00 h after a 97 
12-h fast and brought their 12 h overnight urine. A venous cannula was inserted and after a 10 98 
min interval a 10 mL baseline blood sample was obtained. Participants then consumed 500 mL 99 
of OJ (Tropicana “With Bits”), homogeneity of samples was ensured by mixing and freezing in 100 
bulk and, except for water intake to maintain adequate levels of hydration, no other food or 101 
drink was allowed for the next 4 h.  Further 10 mL blood samples were obtained 1, 2, 3, 4, 5, 6, 102 
7 and 8 h after OJ consumption. Four hours after collection of the first blood sample 103 
participants were provided with a white roll with butter. After blood collection at 8 h, the 104 
cannula was removed and participants were provided with a standard low (poly)phenol meal 105 
(a buttered white roll with ham and cheese and potato chips/crisps) after which they left the 106 
laboratory.  They were instructed to continue the low (poly)phenol diet that evening and 107 
return to the laboratory the next morning in the fasted state, to give the last blood sample. 108 
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In addition, after OJ consumption all urine excreted over the following time periods: 0-5, 109 
5-8, 8-10 and 10-24 h was collected and into sealable flasks kept on ice.  The total volume of 110 
each urine fraction was recorded and 2 mL aliquots were stored at –80 °C prior to analysis. 111 
Blood samples were placed in potassium EDTA tubes (BD Vacutainer Systems, UK) and 112 
immediately placed on ice.  Plasma, separated within 15 min of collection by centrifugation at 113 
2000 g for 15 min at 4 °C (Sorval™ ST, Thermo Scientific, San Jose, CA) was stored at –80 °C 114 
prior to analysis. 115 
Extraction of Orange Juice.  The OJ used in the feeding study was extracted using the 116 
procedure described by Pereira-Caro.10 Briefly, 5 mL aliquots of juice, previously homogenised 117 
using an Ultraturrax homogenizer, were extracted twice with 5 mL of methanol for 2 min and 118 
centrifuged at 2800 g for 15 min at 4 °C. The pellet was extracted in the same manner with 2 119 
mL of methanol. The 2 supernatants were pooled and reduced to dryness in vacuo, redissolved 120 
in 6 mL of 50% aqueous methanol and stored at –80 °C prior to analysis. 121 
Processing of Urine and Plasma.  Urine samples were defrosted, vortexed, centrifuged at 122 
16110 g for 10 min at 5 °C, and passed through 0.45 μm filter discs prior to the analysis of 5 μL 123 
aliquots by HPLC-HR-MS. The extraction of metabolites from the plasma samples has been 124 
carried out as described by Ludwig et al.17 with some modifications. Briefly, plasma samples 125 
were defrosted, vortexed and 400 µL aliquots were mixed with 10 µL of ascorbic acid (10%, 126 
v/v), and 980 µL of 1% formic acid in acetonitrile. One µg of rutin was added to the samples as 127 
internal standard for plasma extraction efficiency. The samples were then vortexed for 1 min 128 
and ultrasonicated for 10 min. After centrifugation at 16110 g for 15 min, supernatants were 129 
reduced to dryness in vacuo using a concentrator plus (Eppendorf, Hamburg, Germany) and 130 
resuspended in 150 µL of distilled water containing 1% formic acid and 50 µL of methanol, 131 
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which was then centrifuged at 16100 g for 10 min and 10 μL aliquots of the supernatant 132 
analysed by HPLC-HR-MS.  The recoveries values of the internal standard were of 78 ± 14% (n 133 
= 20). 134 
HPLC-HR-MS Analysis.  Aliquots of OJ, plasma and urine were analysed using a Dionex 135 
Ultimate 3000 RS UHPLC system comprising of a UHPLC pump, a PDA detector scanning from 136 
200 to 600 nm, and an autosampler operating at 4 °C (Thermo Scientific). The HPLC conditions 137 
were previously described by Pereira-Caro et al.10. Briefly, reverse phase separations were 138 
carried out using a 150 x 4.6 mm i.d. 5 µm 100Å C18 Kinetex column (Phenomenex, 139 
Macclesfield, UK) maintained at 40 °C and eluted at a flow rate of 1.0 mL/min with a 45 min 140 
gradient of 3-50% of 0.1% acidic methanol in 0.1% aqueous formic acid. After passing through 141 
the flow cell of the PDA detector the column eluate was split and 0.2 mL/min directed to an 142 
ExactiveTM Orbitrap mass spectrometer fitted with a heated electrospray ionization probe 143 
(Thermo Scientific) operating in negative ionization mode. Analyses were based on scanning 144 
from 100 to 1000 m/z, with in-source collision-induced dissociation at 25.0 eV. The capillary 145 
temperature was 300 °C, the heater temperature was 150 °C, the sheath gas and the auxillary 146 
gas flow rate were both 20 units, the sweep gas was 3 and the spray voltage was 3.00 kv.  Data 147 
acquisition and processing were carried out using Xcalibur 3.0 software. 148 
Identification of flavanones in OJ and flavanone metabolites and phenolic acid catabolites 149 
in plasma and urine samples were achieved by comparing the exact mass and the retention 150 
time with available standards. In the absence of standards, compounds were tentatively 151 
identified by comparing the theoretical exact mass of the molecular ion with the measured 152 
accurate mass of the molecular ion. Identifications were categorized according to the 153 
Metabolite Standards Initiative Metabolite Identification (MSIMI) levels.18  154 
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(Poly)phenols and p-sympatol in OJ were quantified on the basis of chromatographic peak 155 
areas acquired at 280 nm and 325 nm by reference to standards of hesperetin-7-O-rutinoside, 156 
naringenin-7-O-rutinoside, 4-O-methyl-naringenin-7-O-rutinoside , ferulic acid, p-coumaric ,  157 
sinapic acid and p-sympatol. Hesperetin-O-glucosyl-O-rutinoside was quantified as hesperetin-158 
7-O-rutinoside equivalents, and naringenin-7-O-glucosyl-O-rutinoside and eriodictyol-7-O-159 
rutinoside were quantified as naringenin-7-O-rutinoside equivalents.  160 
 161 
  RESULTS  162 
Analysis of (Poly)phenols in Orange Juice.  HPLC-PDA-HR-MS analysis detected and 163 
quantified 9 compounds in the OJ in agreement with our previous analysis of OJ10. The main 164 
compounds were hesperetin-7-O-rutinoside (hesperidin)(246 µmol) and naringenin-7-O-165 
rutinoside (narirutin) (62 µmol), followed by the flavone apigenin-6,8-C-diglucoside (vicenin-166 
2) (35 µmol) and the hydroxycinnamates ferulic acid-4´-O-glucoside (16 µmol), coumaric acid-167 
4´-O-glucoside (11 µmol) and the flavanone 4´-O-methyl-naringenin-7-O-rutinoside (didymin)  168 
(14 µmol). Small quantities of other flavanones such as hesperetin-7-O-rutinoside-3´-O-169 
glucoside (4 µmol) and eriodictyol-7-O-rutinoside (eriocitrin) (4 µmol) were also present 170 
along with a sinapic acid-O-hexoside (6 µmol). A total of 398 µmol of (poly)phenols were 171 
present  in 500 mL of OJ of which 250 µmol corresponded to the total amount of hesperetin 172 
derivatives (~ 63% of the total (poly)phenol content) and 76 µmol of naringenin derivatives 173 
(~19% of the total (poly)phenol content).  In addition the juice contained  27 µmol of the 174 
amine p-sympatol.  For structures of the fully identified OJ components see Figure 1. 175 
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Identification of Plasma and Urinary Metabolites and Phenolic Catabolites. A total of 176 
19 flavanone metabolites and 65 phenolic and aromatic catabolites were identified or 177 
tentatively identified in plasma and urine collected 0-24 h after the consumption of 500 mL of 178 
OJ.  Typical HPLC-HR-MS chromatograms are illustrated in Figures 2 and 3. 179 
Flavanone metabolites.  The HPLC-HR-MS characteristics such as the retention time, 180 
accurate mass, mDa error between mass found and the accurate mass and the molecular 181 
formula of the flavanone metabolites are summarized in Table 1.  182 
Peaks M1, M2 and M3 (Rts 17.3, 18.1 and 20.2 min) all had a negative exact mass at m/z 183 
623.1245 (+0.48 ppm). The low collision energy spectrum in negative mode showed high 184 
intensity ions at 447.0927 (+1.34 ppm), indicating a neutral loss of 176.0313 Da 185 
(corresponding to an elemental formula (EF) of C6H8O6) (glucuronide moiety) and at 271.0605 186 
(+1.48 ppm) (naringenin daughter ion) indicating a further loss of 176.0322 Da. This 187 
fragmentation pattern partially identifies these compounds as naringenin-O-diglucuronide 188 
isomers. Because there are only three hydroxyls on the naringenin skeleton, based on the 189 
likely HPLC elution order,15 these metabolites are, respectively, the 4´,7-, 5,7- and 4´,5-O-190 
diglucuronides. They were detected in urine but not plasma. 191 
Peak M4 (Rt 22.3 min) yielded a negative charge accurate mass at m/z 527.0490 (+0.18 192 
ppm). The low collision energy spectrum in negative mode showed high intensity ions at 193 
447.0927 (+1.34 ppm), indicating a neutral loss of 79.9563 Da (corresponding to an EF of a 194 
SO3-sulfate moiety), and the presence of SO3- in the fragmentation spectra (i.e. m/z 79.9562); 195 
and ions at 351.0171 (+0.56 ppm), indicating a neutral loss of 176.0319 Da (glucuronide 196 
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moiety). This metabolite, tentatively identified as a naringenin-O-glucuronyl-sulfate, has 197 
previously been detected in human urine after OJ intake.10,13,16 198 
 Peaks M5 and M6 (Rts 27.4 and 28.7 min) had a negative exact mass at 447.0927 (+1.34 199 
ppm) which at low collision energy had a loss of 176.0322 Da (glucuronic acid moiety) 200 
yielding a daughter ion at m/z 271.0605 (+1.48 ppm) (naringenin). Co-chromatography with 201 
authentic standards established that M5 and M6 peaks were naringenin-4´-O-glucuronide and 202 
naringenin-7-O-glucuronide, respectively. These metabolites were present in both plasma and 203 
urine.  204 
Peak M7 (Rt 30.1 min) produced a negative exact mass at 351.0171 (0.56 ppm), which 205 
with the loss of 79.9566 Da (sulfate unit) yielded a fragment at 271.0605 (naringenin). This 206 
metabolite, tentatively identified as naringenin-4´-sulfate, has not been detected before in 207 
either urine or plasma after OJ consumption by humans.  It has, however, recently been 208 
identified in stomach and colon lumen samples of mice after single-pass intestinal perfusion of 209 
naringenin.19 210 
Peaks M8-M10 (Rts 20.9, 21.8 and 25.9 min), which appeared in urine and plasma after OJ 211 
consumption, had a negative accurate mass at m/z 653.1355 (+ 1.07 ppm) which on low 212 
collision energy gave major fragments at m/z 477.1032 (+1.04 ppm) (loss of 176.0322 Da) 213 
(glucuronic acid moiety) and m/z 301.0710 (-1.33 ppm) (hesperetin) with further loss of  214 
176.0322 Da. The three compounds showed the same pattern and were tentatively identified 215 
as hesperetin-O-diglucuronide derivatives. M8 was tentatively identified as hesperetin-3´,7-O-216 
diglucuronide and M9 as hesperetin-5,7-O-diglucuronide, based on previously reported 217 
elution profiles15. M10 is probably the 3´,5-O-diglucuronide. 218 
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Peak M11 (Rt 24.8 min) produced a negative exact mass at m/z 557.0597 (+0.75 ppm) 219 
which on low collision energy yielded major fragments at 477.1032 (+1.04 ppm) loss of 220 
79.9566 Da (sulfate unit) and m/z 301.0710 (-1.33 ppm) (hesperetin) with a loss of 176.0322 221 
Da. This metabolite, which has been detected previously in human urine10, 13,15,16, was 222 
tentatively identified as a hesperetin-O-glucuronyl-sulfate. 223 
Peaks M12-M14 (Rts 30.1, 30.5 and 33.6 min) had a negative exact mass at m/z 477.1032 224 
(+1.04 ppm), which produced an ion at m/z 301.0710 (-1.33 ppm) (hesperetin) upon low 225 
collision energy. This loss of 176.0322 Da corresponded to cleavage of a glucuronic acid 226 
moiety. Co-chromatography with an authentic standard established that M13 was hesperetin-227 
7-O-glucuronide. Because there are only three hydroxyls on the hesperetin skeleton, M12 is 228 
probably the 5-O-glucuronide which is a urinary metabolite while peak M14 is probably the 229 
3´-O-glucuronide. Peaks M13 and M14 were detected in plasma after intake of OJ. 230 
Peaks M15 and M16 (Rts 24.8 and 31.7 min), occurred in urine and plasma, and produced 231 
a negative accurate mass at m/z 381.0279 (+1.31 ppm), which with the 79.9563 Da loss of a 232 
sulfate unit yielded a major fragment at 301.0710 (-1.33 ppm) (hesperetin). Co-233 
chromatography with authentic standard established that M16 was hesperetin-3´-sulfate. 234 
Because there are only three hydroxyls on the hesperetin skeleton, M15 could be tentatively 235 
identified as either the 5- or the 7-sulfate. 236 
Peak M17 (Rt 23.7 min) had a negative exact mass at m/z 543.0808 (+0.92 ppm) with 237 
fragment with a loss of 162.0519 (+1.85 ppm) (corresponding to an EF C6H8O5, hexose group) 238 
to produce a daughter ion at m/z 381.0279 (+1.31 ppm), which with an 79.9563 Da loss of a 239 
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sulfate unit yielded a fragment at 301.0710 (-1.33 ppm) (hesperetin). This metabolite was 240 
tentatively identified as a hesperetin-O-glucosyl-sulfate. It was found only in urine samples. 241 
Peak M18 (Rt 29.6 min), an urinary metabolite, produced a negative accurate mass at m/z 242 
367.0122 (+1.08 ppm) which with low collision energy gave rise to a m/z 287.0553 (- 1.05 243 
ppm) (eriodictyol moiety). The loss of 79.9569 Da indicates cleavage of a sulfate ion. This peak 244 
was, therefore, tentatively identified as an eriodictyol-sulfate. 245 
Peak M19 (Rt 22.1 min) had a negative exact mass at m/z 543.0447 (+1.47 ppm). The low 246 
collision energy spectrum in negative mode showed two major ions at 463.0876 (+1.07 ppm), 247 
indicating a neutral loss of 79.9571 Da (sulfate unit) and at 367.0122 (+1.08 ppm) indicating a 248 
loss of 176.0325 Da (glucuronide structure). This fragmentation pattern partially identifies 249 
this compound as an eriodictyol-O-glucuronide-sulfate not previously detected in human 250 
urine. 251 
The structures of the identified flavanone metabolites are presented in Figure 4. 252 
Phenolic and aromatic catabolites. The HPLC-HR-MS characteristics the phenolic and 253 
aromatic are summarized in Table 2.  A total of 14 phenylpropanoid acid derivatives (C1-C14) 254 
were identified in human plasma and/or urine after OJ consumption, 4 of them were free 255 
phenolic acids (3´-hydroxycinnamic acid, 4´-hydroxycinnamic acid, ferulic acid and isoferulic 256 
acid) and 10 phase II metabolites (Table 2), mainly glucuronide and sulfate derivatives of 257 
coumaric, caffeic, ferulic and isoferulic acids. All, except peak C5, were identified by comparing 258 
the exact mass and the retention time with authentic standards. Peak C5 was tentatively 259 
identified as coumaric acid-4´-sulfate as this peak presented a negative exact mass at m/z 260 
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242.9953 (+2.41 ppm) which with low collision energy gave rise to a m/z 163.0388 (+ 1.05 261 
ppm) (coumarate moiety). The loss of 79.9564 Da indicated cleavage of a sulfate ion.  262 
In addition, 20 phenylpropionic acid derivatives, 8 free phenolic acids and 12 conjugate 263 
derivatives (glucuronide and sulfate conjugates) were detected in plasma and urine. Peaks 264 
C15, C17-27, C29, C30 and C34 (Table 2) were identified based on comparisons with 265 
authentic standards. Peak C16 had a negative accurate mass at m/z 211.0607 (-3.32 ppm) 266 
which with low collision energy gave rise to a m/z 181.0492 (+0.55 ppm) corresponding to a 267 
standard of 3-(3´-hydroxyphenyl)hydracrylic acid, with loss of 30.0115 Da (cleavage of a 268 
methoxy ion).  269 
Peaks C27 and 28 had a negative exact mass at m/z 275.0225 (-1.82 ppm) and a fragment 270 
at m/z 195.0657 (-2.64 ppm) (corresponding to a standard of 3-(3´-hydroxy-4´-271 
methoxyphenyl)propionic acid) indicating a further loss of 79.9568 Da (sulfate ion). The 272 
identity of peak C27 was confirmed by reference to a standard of 3-(3´-273 
methoxyphenyl)propionic acid-4´-sulfate. The later eluting C28 was tentatively identified as 3-274 
(4´-methoxyphenyl)propionic acid-3´-sulfate. This is in keeping with the sulfates of caffeic acid 275 
(C7 and C9), 3-(hydroxyphenyl)propionic acid (C21 and C22), and 3-276 
(methoxyphenyl)propionic acid (C27 and C28), where the 3′-derivative elutes after the 4'-277 
isomer.  278 
Peak C31 had a negative exact mass at m/z 341.0874 (-2.03 ppm), yielding at low collision 279 
energy a fragment at m/z 165.0547 (-0.48 ppm). The loss of 176.0321 Da corresponded to a 280 
glucuronic acid moiety. This catabolite was putatively identified as 3-(phenyl)propionic acid-281 
3´-O-glucuronide. Peaks C32 and C33 presented a negative accurate mass at m/z 245.0123 (-282 
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3.53 ppm), which yielded an ion at m/z 165.0547 (-0.48 ppm) (corresponding to a standard of 283 
3-(3´/4´-hydroxyphenyl)propionic acid) upon low collision energy. The loss of 79.9576 Da 284 
(sulfate ion) tentatively identified these two catabolites as 3-(phenyl)propionic acid sulfate 285 
isomers. As has been described above, the earlier eluting peak C32 is tentatively identified as 286 
3-(phenyl)propionic acid-4´-sulfate and C33 as 3-(phenyl)propionic acid-3´-sulfate.  287 
Peaks C35-C46 corresponded to phenylacetic acid derivatives. Among them, peaks C35, 288 
C39, C43-46 were identified by reference to standards and comprised a range of free phenolic 289 
acids (see Table 2). Peak C36 had a negative exact mass at m/z 327.0719 (-2.75 ppm), yielding 290 
at low collision energy a fragment at m/z 151.0390 (-0.66 ppm) (hydroxyphenylacetic acid 291 
moiety). The loss of 176.0329 Da corresponded to a glucuronic acid group. This catabolite was 292 
putatively identified as a hydroxyphenylacetic acid-O-glucuronide. Peaks C37 and C38 293 
presented negative exact masses at m/z 230.9964 (-3.03 ppm) and a fragment at m/z 294 
151.0390 (-0.66 ppm) (corresponding to a standard of hydroxyphenylacetic acid) indicating a 295 
further loss of 79.9574 Da (sulfate ion). The HPLC elution order of the sulfates indicates that 296 
C37 is probably 3′-hydroxyphenylacetic acid-4′-sulfate and C38 is 4′-hydroxyphenylacetic 297 
acid-3′-sulfate.  298 
Peak C40 had a negative accurate mass at m/z 357.0828 (-3.30 ppm), yielding at low 299 
collision energy a fragment at m/z 181.0490 (+2.96 ppm) (hydroxymethoxyphenylacetic acid 300 
moiety). The loss of 176.0338 Da allowed the putative identification of this catabolite as a 301 
methoxyphenylacetic acid-O-glucuronide with glucuronic acid moiety at either the 3’- or 4’-302 
positions. Peaks C41-C42 had a negative exact mass at m/z 261.0073 (-3.64 ppm) and 303 
fragments at m/z 181.0490 (+2.96 ppm) indicating a further loss of 79.9583 Da, which 304 
indicates these compounds are methoxyphenylacetic acid sulfate isomers. In view of the 305 
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elution order C41 was tentatively identified as 3’-methoxyphenylacetic acid-4’-sulfate and 306 
C42 as 4’-methoxyphenylacetic acid-3’-sulfate.   307 
Among the benzoic acid and hydroxycarboxylic acid derivatives identified, 7 corresponded 308 
to free phenolics (C47, C51-54, C57, C58, see Table 2) and have been identified based on their 309 
comparison with authentic standards. Peak C48 presented a negative accurate mass at m/z 310 
329.0513 (-3.04 ppm), yielding at low collision energy a fragment at m/z 153.0183 (-0.65 311 
ppm) (corresponding to a standard of 3,4-dihydroxybenzoic acid). The loss of 176.0330 Da 312 
allowed the identification of this catabolite as hydroxybenzoic acid-O-glucuronide derivative. 313 
Peaks C49-C50 and C55-C56 presented negative exact masses at m/z 232.9756 (-2.58 ppm) 314 
and at m/z 216.9807 (-2.77 ppm), respectively, yielding at low collision energy fragments at 315 
m/z 153.0183 (-0.65 ppm) (corresponded to a standard of 3,4-dihydroxybenzoic acid) and 316 
137.0230 (+2.19 ppm) (corresponded to a hydroxybenzoic acid standard), with the loss of 317 
79.9583 Da, facilitating the tentative identification of peaks C49-C50 as hydroxybenzoic acid-318 
sulfate isomers with the elution order implying that C49 is 3-hydroxybenzoic acid-4-sulfate 319 
and C50 is 4-hydroxybenzoic acid-3-sulfate.  Likewise the benzoic acid-sulfate isomers, C55-320 
C56, are tentatively identified as benzoic acid-4-sulfate (C55) and benzoic acid-3-sulfate 321 
(C56). 322 
Other groups of phenolic and aromatic acids identified in plasma and urine after OJ 323 
consumption by humans were the benzenetriol and benzoylglycine derivatives which 324 
comprises three hydroxyphenol derivatives (peaks C59-C61, see Table 2) and two 325 
hydroxyhippuric acid derivatives (peak C63-C64, see Table 2). Except for peak C62, all were 326 
identified based on the comparison of their exact mass and retention time with authentic 327 
standards. Peak C62 had a negative accurate mass at m/z 370.0778 (-5.67 ppm) which with 328 
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low collision energy gave rise to a fragment at m/z 194.0455 (-4.12 ppm) (corresponding to a 329 
standard of hydroxyhippuric acid). The loss of 176.0323 Da allowed the tentative 330 
identification of this catabolite as hippuric acid-O-glucuronide. Finally, the fragmentation and 331 
retention time of peak C65 corresponded to those of a standard of hippuric acid (Table 2). 332 
 333 
 DISCUSSION 334 
This paper describes a comprehensive characterization of 19 flavanone metabolites and 65 335 
colon-derived phenolic acid catabolites in human plasma and urine after OJ consumption. 336 
Some hesperetin and narigenin metabolites have been detected in earlier studies. 8-13,15 337 
However, the current investigation identified 2 urinary flavanone metabolites, naringein-4´-338 
sulfate and an eriodictyol-O-glucuronyl-sulfate, and more than 40 phenolic catabolites that 339 
had not previously been identified in human plasma and/or urine after OJ intake. 340 
After ingestion and during transport through the small intestine, the 7-O-rutinosides of 341 
hesperetin and naringenin undergo limited hydrolysis of the O-rhamnose-glucose unit and 342 
release of the aglycone. As a consequence relatively little absorption and phase II metabolism 343 
of the aglycone occurs in the enterocyte. The sugar moiety is a major determinant of the 344 
absorption site and bioavailability of flavanones.15,20 Flavanone monoglucosides are absorbed 345 
in the small intestine after hydrolysis by lactase phlorizin hydrolase present in the gut lumen 346 
brush border21 and/or cytosolic β-glucosidase in the intestinal cells.22  In contrast, substantial 347 
amounts of flavanone rutinosides are not hydrolysed and substantial amounts reach the colon 348 
intact14 where the resident microbiota catalyse deconjugation of the sugar moiety 1. A portion 349 
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of the released aglycones is absorbed and transformed by the phase II enzymes before 350 
entering in circulatory system. 351 
In the current study 10 hesperetin, 7 naringenin and 2 eriodictyol metabolites were 352 
identified in urine after consumption of OJ while 8 hesperetin and 3 naringenin metabolites 353 
were detected in plasma (Table 1, Figure 4). None of the parent OJ flavanone glycosides were 354 
detected in either urine or plasma. These results are in keeping with earlier by HPLC-MS based 355 
studies which identified flavanone metabolites in human biological fluids. For instance, Mullen 356 
and co-workers12 identified a hesperetin-O-diglucuronide, a naringenin-O-diglucuronide, 357 
naringenin-7-O-glucuronide and hesperetin-O-glucuronyl-sulfate in urine, and hesperetin-7-O-358 
glucuronide in both urine and plasma after consumption of OJ by healthy subjects. In a further 359 
study, Bredsdorft et al.15 identified hesperetin-3´,7-O-diglucuronide, hesperetin-5,7-O-360 
diglucuronide, naringenin-4´-O-glucuronide, hesperetin-3´-O-glucuronide and hesperetin-3´-O-361 
sulfate in urine after ingestion of OJ and an α-rhamnosidase-treated OJ. Two recent studies 362 
carried out by our group detected additional metabolites, namely naringenin-4´,7-O-363 
diglucuronide, naringenin-5,7-O-diglucuronide, naringenin-4´,5-O-diglucuronide, hesperetin-364 
3´,5-O-diglucuronide and hesperetin-O-glucosyl-sulfate and eriodictyol-sulfate in urine after 365 
ingestion of a pulp-enriched OJ10 and after acute OJ intake with and without a 366 
microencapsulated probiotic.13 As well as these metabolites, naringenin-4´-sulfate and an 367 
eriodictyol-O-glucuronyl-sulfate were detected in both plasma and urine in the current study. 368 
Further metabolites were detected in urine, namely hesperetin-5-O-glucuronide, a naringenin-369 
O-glucuronyl-sulfate and an eriodictyol-O-glucuronyl-sulfate.  370 
 Not all the flavanone aglycones released in the distal GI tract are absorbed as sizable 371 
amounts undergo microbiota-mediated ring fission and yield a family of low molecular weight 372 
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phenolic catabolites which before being absorbed, in some instances, undergoing additional 373 
metabolism locally and/or in the liver and kidney before entering the systemic circulation and 374 
undergoing renal excretion.10, 11  Analysis of urinary phenolic catabolites after OJ consumption 375 
has emphasized their involvement in the overall bioavailability of OJ (poly)phenols as well as 376 
subsequent hepatic conversions that lead to hippuric acid and its hydroxylated 377 
analogues10,11,13. Phase II metabolites of phenolic catabolites that have previously been 378 
identified in urine include coumaric acid-3´-O-glucuronide, coumaric acid-4´-sulfate, 3-379 
(phenyl)propionic acid-4′-O-glucuronide, 3-(4´-hydroxyphenyl)propionic acid-4´-sulfate, a 380 
hydroxyphenylacetic acid-O-glucuronide and a hippuric acid-O-glucuronide8.  In the current 381 
study with OJ, analysis of urine and plasma by HPLC-HR-MS enabled a much more 382 
comprehensive profile of phenolic catabolites to be obtained (Table 2).  These findings, 383 
together with the results of earlier studies10,13,14 and in vitro fecal incubations of OJ and OJ 384 
(poly)phenols11, 23 have enabled us to propose up-dates of potential catabolic routes for the 385 
conversion of hesperetin-7-O-rutinoside, naringenin-7-O-rutinoside, ferulic acid-4´-O-386 
glucoside and p-sympatol (Figures 5-6).  For simplification the potential routes incorporate 387 
many, but not all, of the compounds listed in Table 2. 388 
In the preparation of the proposed pathways illustrated in Figures 5 and 6, the following 389 
points were taken into consideration.  The rupture of the flavanone skeleton is primarily a 390 
feature of the gut microflora while subsequent methylation and glucuronide, sulfate and 391 
glycine conjugation are mammalian in origin.  Dehydroxylation and demethoxylation are 392 
almost certainly mediated by the gut microflora while demethylation and hydrogenation steps 393 
can be mediated by both microbial and mammalian enzymes. For convenience, the pathways 394 
in Figures 5 and 6 show C6−C3 catabolites being converted by two α-oxidations to C6-C1 395 
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compounds by microflora and/or mammalian enzymes.  However, it is possible the C6−C3 396 
catabolites progress directly to C6−C1 structures via β-oxidation and that C6−C2 catabolites 397 
arise by independently, possibly by α-oxidation.  In reality, further complexity is introduced as 398 
there are multiple points at which catabolites might be absorbed. For example, a percentage of 399 
some C6−C3 catabolites could be absorbed and undergo β-oxidation and/or mammalian phase 400 
II conjugation while the balance is subjected to microbial hydrogenation and/β-oxidation 401 
prior to absorption and mammalian conjugation. Also for some catabolites mammalian 402 
conjugation either does not occur or is incomplete. 403 
Figure 5 indicates that hesperetin, released through colonic bacteria-mediated 404 
deglycosylation, as well as being glucuronidated and sulfated, undergoes ring fission yielding 405 
3-(3′-hydroxy-4′-methoxyphenyl)hydracrylic acid, 3-(3′-hydroxyphenyl)hydracrylic acid and 406 
isoferulic acid from the B-ring and phloroglucinol from the A-ring. It is noteworthy that 3-(3´-407 
hydroxy-4´-methoxyhydroxyphenyl)hydracrylic acid has been reported as potential 408 
biomarker of  the intake of OJ containing hesperetin-O-glycosides.10,13 Urinary excretion of 3-409 
(3′-hydroxyphenyl)hydracrylic acid, which also increases after OJ intake, has also been 410 
detected in urine after consumption of (+)catechin 24, green tea25 and mixed wine and grape 411 
juice26,27. The hesperetin catabolite, isoferulic acid, is further converted to dihydro-isoferulic 412 
acid [3-(3´-hydroxy-4´-methoxyphenyl)propionic acid] which is demethylated yielding 413 
dihydrocaffeic acid [3-(3´,4´-dihydroxyphenyl)propionic acid]. Dihydro-isoferulic acid can also 414 
be degraded to 3´-hydroxy-4´-methoxyphenylacetic acid which is further converted to 3-415 
hydroxy-4-methoxybenzoic acid via shortening of the side chain.  Phase II metabolites of 416 
dihydro-isoferulic acid, in the form of dihydro-isoferulic acid-3´-sulfate, dihydro-isoferulic 417 
acid-3´-O-glucuronide, are also produced while dihydrocaffeic acid can be converted to sulfate 418 
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and glucuronide derivatives of 3-(hydroxyphenyl)propionic acid (Figure 5). Other products, 419 
potentially derived from dihydrocaffeic acid via successive dehydroxylations, include 3-(3´-420 
hydroxyphenyl)propionic acid and 3-(phenyl)propionic acid, which could, respectively, 421 
contribute to the urinary pools of 3´-hydroxyhippuric acid and hippuric acid. In addition, 422 
dihydrocaffeic acid may be converted to 3-(4´-hydroxyphenyl)propionic acid which, via the 423 
pathways illustrated in Figure 5, could lead to the accumulation of  4´-hydroxyhippuric acid.  424 
The proposed catabolic routes for naringenin begin with ring fission yielding 425 
phloroglucinol from the A-ring and 3-(4´-hydroxyphenyl)propionic acid from ring B. 3-(4´-426 
Hydroxyphenyl)propionic acid undergoes dehydroxylation and shortening of the side chain to, 427 
respectively, produce 3-(phenyl)propionic acid and 4´-hydroxyphenylacetic acid, which, it is 428 
proposed, are ultimately converted to hippuric acid and 4´-hydroxyhippuric acid via the 429 
pathways shown in Figure 6.  Other phenolics identified in plasma and/or urine after OJ 430 
consumption, such as 4´-hydroxycinnamic acid and dihydroferulic acid could be derived from 431 
ferulic acid, which occurs in OJ as ferulic acid-4´-glucoside. In addition, ferulic acid-4´-sulfate, 432 
ferulic acid-4´-O-glucuronide, dihydroferulic acid-4´-O-glucuronide and dihydroferulic acid-4´-433 
sulfate were all identified in plasma and urine after OJ consumption. Catabolism of 434 
dihydroferulic acid via the network illustrated in Figure 6 leads to the formation of hippuric 435 
acid, 4′-hydroxyhippuric acid and benzoic acid-4-sulfate. 436 
After OJ consumption, plasma and urine contain elevated levels of 4′-hydroxymandelic 437 
acid (Pereira-Caro, unpublished), the likely source of which is not flavanones but the amine p-438 
sympatol (aka p-synephrine) which was present in the juice. Tritium-labeled p-sympatol has 439 
been shown to be converted to 4′-hydroxymandelic acid following ingestion by humans.28  A 440 
potential pathway for the three step conversion of p-sympatol to 4’-hydroxymandelic acid is 441 
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shown in Figure 6. The plasma Cmax of p-sympatol occurs ~1 h after OJ intake indicating that 442 
the conversions are likely to be enterocyte/hepatic in origin consistent with findings using 443 
tritated sympatol.28  444 
It is noteworthy, that except for compounds originating from hesperetin, no methylated 445 
flavanone metabolites were detected either in plasma or urine after OJ intake. This supports 446 
the view that the methylation is less prevalent in the large intestine than the upper GIT 17, and 447 
also implies that there is little or no hepatic methylation of flavanone metabolites.  This may 448 
be because, except for eriodictyol-7-O-rutinoside, a very minor component, OJ flavanones lack 449 
a catechol group on the B-ring which is a requirement for catechol-O-methyltransferase 450 
activity.  The appearance of several methoxy-phenolic catabolites, such as C27 and C41, 451 
indicates the some degree of methylation of phenolic acids does take place. 452 
A number of the phenolic acid catabolites, such as hippuric acid, were present in 0-24 h 453 
urine collected before supplementation, however, earlier studies have identified those which 454 
increase following OJ consumption,10,11,13 and this was taken into account in the preparation of 455 
the pathways illustrated in Figures 5 and 6.  The detailed elucidation of metabolites and 456 
catabolites appearing in the circulatory system and excreted in urine after OJ intake provides a 457 
valuable foundation for time-course studies and quantitative analyses after supplementation. 458 
This will help identify potentially bioactive compounds to test using in vitro models of human 459 
cell lines in order to assist elucidation the mechanisms underlying the protective effects of OJ 460 
consumption.    461 
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Figure Legends 570 
 571 
Figure 1. Structures of compounds identified in orange juice. 572 
Figure 2.  HPLC-HR-MS traces of flavanone metabolites in urine samples collected 10-24h 573 
after the consumption of orange juice. For peak identification see Table 1. 574 
Figure 3. HPLC-HR-MS traces of selected flavanone catabolites identified in urine samples 575 
collected 10-24h after the consumption of orange juice.  For peak identification see Table 2. 576 
Figure 4. Structures of metabolites of hesperetin and naringenin identified in 577 
plasma/urine after consumption of orange juice. 578 
Figure 5.  Proposed pathways for the catabolism of hesperetin by colonic microbiota and 579 
mammalian phase II metabolism. Red arrows indicate microbiota-mediated steps, blue 580 
arrow represent mammalian enzyme-mediated conversions. Based on the data presented 581 
in this paper and earlier orange juice feeding studies and in vitro anaerobic incubations of 582 
fecal material with flavanones and orange juice.9,10,22  GlcUA - glucuronide; * - potential 583 
intermediate that did not accumulate in detectable amounts. 584 
Figure 6.  Proposed pathways for the catabolism of naringenin, ferulic acid and p-sympatol 585 
by colonic microbiota and mammalian phase II metabolism. Red arrows indicate 586 
microbiota-mediated steps, blue arrow represent mammalian enzyme-mediated 587 
conversions. Based on the data presented in this paper and earlier orange juice feeding 588 
studies and in vitro anaerobic incubations of fecal material with flavanones and orange 589 
juice.9,10,22  GlcUA - glucuronide; * - potential intermediates that did not accumulate in 590 
detectable amounts. 591 
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mass  [m/z]- 




     
  
M1 Naringenin-4´,7-O-diglucuronide C27H27O17 623.1248 623.1245 0.48 17.3 U 2 
M2 Naringein-5,7-O-diglucuronide C27H27O17 623.1248 623.1245 0.48 18.1 U 2 
M3 Naringenin-4´,5-O-diglucuronide C27H27O17 623.1248 623.1245 0.48 20.2 U 2 
M4 Naringenin -O-glucuronyl-sulfate C21H19O4S 527.0490 527.0491 0.18 22.3 U 2 
M5 Naringenin-4´-O-glucuronide C21H19O4  447.0921 447.0927 1.34 27.4 U, P 1 
M6 Naringenin-7-O-glucuronide C21H19O4  447.0921 447.0927 1.34 28.7 U, P 1 
M7 Naringenin-4´-sulfate C15H11O8S 351.0169 351.0171 0.56 30.1 U, P 2 
 
      
  
Hesperetin metabolites 
     
  
M8 Hesperetin-3´,7-O-diglucuronide C38H30O18 653.1348 653.1355 1.07 20.9 U, P 2 
M9 Hesperetin-5,7-O-diglucuronide C38H30O18 653.1348 653.1355 1.07 21.8 U, P 2 
M10 Hesperetin-3´,5-O-diglucuronide C38H30O18 653.1348 653.1355 1.07 25.9 U, P 2 
M11 Hesperetin-O-glucuronyl-sulfate C22H22O15S 557.0595 557.0597 0.75 24.8 U, P 2 
M12 Hesperetin-5-O-glucuronide C22H22O12 477.1027 477.1032 1.04 30.1 U 2 
M13 Hesperetin-7-O-glucuronide C22H22O12 477.1027 477.1032 1.04 30.5 U, P 1 
M14 Hesperetin-3´-O-glucuronide C22H22O12 477.1027 477.1032 1.04 33.6 U, P 2 
M15 Hesperetin-sulfate C16H14O9S 381.0274 381.0279 1.31 24.8 U, P 2 
M16 Hesperetin-3´-sulfate C16H14O9S 381.0274 381.0279 1.31 31.7 U, P 1 
M17 Hesperetin-O-glucosyl-sulfate C22H23O14S 543.0803 543.0808 0.92 23.7 U 2 
 
      
  
Eriodictyol metabolites 
     
  
M18 Eriodictyol sulfate  C15H11O9S 367.0118 367.0122 1.08 29.6 U, P 2 
M19 Eriodictyol-O-glucuronyl-sulfate  C21H19O15S 543.0439 543.0447 1.47 22.1 U, P 2 
a U, urine; P, plasma.  
bMetabolite standards initiative (MSI) metabolite identification (MI) levels17. Reference compounds were available for all compounds 
identified at MSI MI level 1
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Table 2. HPLC-HR-MS Based Identifications of Phenolic Acid Catabolites in Human Plasma and Urine Collected 0-24 h After 
















Phenylpropanoid acid derivatives 
    
  
C1 22.70 3'-Hydroxycinnamic acid C9H7O3 163.0390 163.0388 1.05 U 1 
C2 15.21 Coumaric acid-3'-O-glucuronide C15H15O9 339.0711 339.0712 -0.42 U 1 
C3 19.33 4'-Hydroxycinnamic acid C9H7O3 163.0390 163.0388 1.05 U 1 
C4 10.53 Coumaric acid-4´-O-glucuronide C15H15O9 339.071 339.0712 -0.59 U 1 
C5 12.32 Coumaric acid-4'-sulfate  C9H7O6S 242.9958 242.9953 2.41 U 2 
C6 14.00 Caffeic acid-3'-O-glucuronide C15H15O10 355.0660 355.0659 0.21 U 1 
C7 11.94 Caffeic acid-3´-sulfate  C9H7O7S 258.9907 258.9917 -3.86 U, P 1 
C8 11.03 Caffeic acid-4´-O-glucuronide C15H15O10 355.0659 355.0659 0.00 U 1 
C9 10.31 Caffeic acid-4´-sulfate  C9H7O7S 258.9907 258.9905 0.77 U, P 1 
C10 22.42 Ferulic acid C10H9O4 193.0495 193.0492 1.74 U, P 1 
C11 13.88 Ferulic acid-4´-O-glucuronide C16H17O10 369.0816 369.0825 -2.38 U, P 1 
C12 13.99 Ferulic acid-4´-sulfate C10H9O7S 273.0063 273.0074 -3.85 U, P 1 
C13 24.32 Isoferulic acid C10H9O4 193.0495 193.0496 -0.34 U,P 1 
C14 18.37 Isoferulic acid-3´-O-glucuronide C16H17O10 369.08162 369.0825 -2.38 U, P 1 
 




Phenylpropionic acid derivatives 
    
  
C15 8.74 3-(3´-Hydroxyphenyl)hydracrylic acid  C9H9O4 181.0493 181.0492 0.55 U, P 1 
C16 11.32 3-(3´-Hydroxy-4´-methoxyphenyl)hydracrylic acid  C10H11O5 211.0600 211.0607 -3.32 U, P 1 
C17 11.20 3-(3´,4´-Dihydroxyphenyl)propionic acid  C9H9O4 181.0495 181.0489 3.31 U, P 1 
C18 11.59 3-(3´-Hydroxyphenyl)propionic acid-4´-O-glucuronide  C15H17O10 357.0816 357.0816 0.00 U 1 
C19 14.11 3-(Phenyl)propionic acid-4´-O-glucuronide C15H17O9 341.0867 341.0874 -2.03 U 1 
C20 12.57 3-(4´-Hydroxyphenyl)propionic acid-3-O-glucuronide C15H17O10 357.0816 357.0816 0.00 U 1 
C21 9.11 3-(3´-Hydroxyphenyl)propionic acid-4´-sulfate   C9H9O7S 261.0063 261.006 1.34 U, P 1 
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C22 9.48 3-(4´-Hydroxyphenyl)propionic acid-3´-sulfate   C9H9O7S 261.0063 261.0067 -1.34 U, P 1 
C23 19.42 3-(3´-Methoxy-4´-hydroxyphenyl)propionic acid  C10H11O4 195.0652 195.0648 1.98 U, P 1 
C24 14.85 3-(3'-Methoxyphenyl)propionic acid-4´-O-glucuronide C16H19O10 371.0973 371.0979 -1.69 U, P 1 
C25 21.45 3-(3´-Hydroxy-4´-methoxyphenyl)propionic acid C10H11O4 195.0652 195.0657 -2.64 U, P 1 
C26 17.44 3-(4´-Methoxyphenyl)propionic-3´-O-glucuronide  C16H19O10 371.0973 371.0967 1.54 U, P 1 
C27 12.23 3-(3´-Methoxyphenyl)propionic acid-4´-sulfate  C10H11O7S 275.0220 275.0225 -1.82 U, P 1 
C28 13.75 3-(4´-Methoxyphenyl)propionic acid-3´-sulfate  C10H11O7S 275.0220 275.0225 -1.82 U, P 2 
C29 18.33 3-(3´-Hydroxyphenyl)propionic acid C9H9O3 165.0546 165.0547 -0.48 U, 1 
C30 16.78 3-(4´-Hydroxyphenyl)propionic acid C9H9O3 165.0546 165.0547 -0.48 U, P 1 
C31 12.64 3-(Phenyl)propionic acid-3´-O-glucuronide C15H17O9 341.0867 341.0874 -2.03 U 2 
C32 11.73 3-(Phenyl)propionic acid-4´-sulfate  C9H9O6S 245.0114 245.0123 -3.53 U 2 
C33 12.32 3-(Phenyl)propionic acid-3´-sulfate C9H9O6S 245.0114 245.0123 -3.53 U 2 
C34 12.20 3-(Phenyl)propionic acid   C9H9O2 149.0597 149.0593 2.72 U,P 1 
         
 
 
Phenylacetic acid derivatives 
    
  
C35 7.72 3´,4´-Dihydroxyphenylacetic acid C8H7O4 167.0338 167.0332 3.59 U 1 
C36 7.97 Hydroxyphenylacetic acid-O-glucuronide C14H15O9 327.071 327.0719 -2.75 U, P 2 
C37 6.62 Hydroxyphenylacetic acid-4′-sulfate  C8H7O6S 230.9957 230.9964 -3.03 U 2 
C38 7.21 Hydroxyphenylacetic acid-3’-sulfate  C8H7O6S 230.9957 230.9964 -3.03 U, P 2 
C39 14.14 3´-Methoxy-4´-hydroxyphenylacetic acid   C9H9O4 181.0495 181.049 2.96 U 1 
C40 7.23 Methoxyphenylacetic acid-O-glucuronide C15H17O10 357.0816 357.0828 -3.30 U, P 2 
C41 7.19 3'-Methoxyphenylacetic acid-4′-sulfate  C9H9O7S 261.0063 261.0073 -3.64 U, P 2 
C42 8.65 4'-Methoxyphenylacetic acid-3′-sulfate   C9H9O7S 261.0063 261.0073 -3.64 U, P 2 
C43 22.28 3´,4´-Dimethoxyphenylacetic acid C10H11O4 195.0652 195.0653 -0.59 U 1 
C44 12.53 3´-Hydroxyphenylacetic acid C8H7O3 151.0389 151.0390 -0.66 U, P 1 
C45 11.34 4´-Hydroxyphenylacetic acid C8H7O3 151.0389 151.0390 -0.66 U, P 1 
C46 16.84 Phenylacetic acid C8H7O2 135.0440 135.0445 -3.70 U 1 
 




Benzoic acid derivatives 
    
  
C47 6.63 3,4-Dihydroxybenzoic acid C7H5O4 153.0182 153.0183 -0.65 U, P 1 
C48 3.85 Hydroxybenzoic acid-O-glucuronide C13H13O10 329.0503 329.0513 -3.04 U 2 
C49 4.83 3-Hydroxybenzoic acid-4-sulfate  C7H5O7S 232.9750 232.9756 -2.58 U 2 
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C50 5.50 4-Hydroxybenzoic acid-3-sulfate  C7H5O7S 232.9750 232.9756 -2.58 U 2 
C51 13.51 3-Methoxy-4-hydroxybenzoic acid  C8H7O4 167.0339 167.0337 1.11 U 1 
C52 15.00 3-Hydroxy-4-methoxybenzoic acid    C8H7O4 167.0339 167.0336 1.71 U 1 
C53 12.14 3-Hydroxybenzoic acid C7H5O3 137.0233 137.023 2.19 U 1 
C54 9.83 4-Hydroxybenzoic acid C7H5O3 137.0233 137.0227 4.38 U 1 
C55 5.98 Benzoic acid-4-sulfate  C7H5O6S 216.9801 216.9807 -2.77 U, P 2 
C56 7.41 Benzoic acid-3-sulfate  C7H5O6S 216.9801 216.9807 -2.77 U 2 
         
 
 
Hydroxycarboxylic acid derivatives 
    
  
C57 4.02 3´-Methoxy-4'-hydroxymandelic acid C9H9O5 197.0444 197.0453 -4.57 U, P 1 
C58 2.96 4´-Hydroxymandelic acid C8H7O4 167.0338 167.034 -1.20 U, P 1 




    
  
C59 2.98 1,3,5-Trihydroxyphenol   C6H5O3 125.0233 125.0234 -0.80 U 1 
C60 3.36 1,2,3-Trihydroxyphenol  C6H5O3 125.0233 125.0236 -2.40 U 1 
C61 6.63 1,2-Dihydroxyphenol  C6H5O2 109.0284 109.0282 1.83 U 1 
 





    
  
C62 9.44 Hippuric acid-O-glucuronide C15H16NO10 370.0757 370.0778 -5.67 U, P 2 
C63 7.50 3´-Hydroxyhippuric acid C9H8NO4 194.0447 194.0455 -4.12 U, P 1 
C64 6.84 4´-Hydroxyhippuric acid C9H8NO4 194.0447 194.0455 -4.12 U, P 1 
C65 10.76 Hippuric acid C9H8NO3 178.0498 178.0495 1.68 U, P 1 
aP, plasma; U, urine 
bMetabolite standards initiative (MSI) metabolite identification (MI) levels.17  Reference compounds were available for all compounds 
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